VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MDGL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MDGLMadrigal Pharmaceuticals, Inc.
$399.63$9.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMDGLQuarterly Balance Sheet

Madrigal Pharmaceuticals, Inc. (MDGL) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Madrigal Pharmaceuticals, Inc. (MDGL) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

MDGL Balance Sheet

Quarterly statement

MDGL Balance Sheet

Madrigal Pharmaceuticals, Inc. (MDGL) balance sheet — 23-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets1.39B1.2B1.18B1.25B1.35B1B987.98M1.03B1.06B1.09B1.07B637.28M235.47M301.6M331.28M361.37M157.11M214.55M221.17M271.68M
Cash & Short-Term Investments960.97M838.75M817.93M983.56M1.11B797.02M843.07M926.25M998.63M1.06B1.06B634.13M232.35M298.42M329.48M358.77M153.19M211.77M219.95M270.35M
Cash Only514.64M292.73M232.19M198.69M295.69M186.19M183.65M100.02M232.68M494.6M622.52M99.92M62.05M77.2M113.31M331.55M59.34M53.27M42.28M36.27M
Short-Term Investments446.32M546.03M585.74M784.87M814.05M610.83M659.42M826.23M765.94M563.2M436.55M534.22M170.3M221.22M216.17M27.23M93.85M158.49M177.67M234.08M
Accounts Receivable227.38M192.31M187.36M134.48M113.28M79.23M61.43M53.82M30.46M6.9M0000000000
Days Sales Outstanding44.7647.4346.5235.530.8330.0737.7937.5327.6442.89----------
Inventory122.59M99.39M112.07M74.84M69.32M63.5M55.24M34.07M8.71M7.07M854K000000000
Days Inventory Outstanding270.03240.49313.29271.24337.13595.98890.52571.27337.45567.03----------
Other Current Assets76.18M68.72M64.95M52.89M5M63.6M28.24M18.79M25.86M19.96M14.04M3.15M3.12M3.18M1.81M2.6M0000
Total Non-Current Assets47.28M45.47M45.02M13.82M15.78M12.03M8.65M9.32M9.6M8.06M8.33M3.27M2.5M866K1.17M1.2M1.53M1.85M1.49M1.65M
Property, Plant & Equipment26.81M17.17M14.24M6.44M8.3M7.48M4.01M4.59M4.78M3.15M3.33M3.27M2.5M866K1.17M1.2M1.53M1.85M1.49M1.65M
Fixed Asset Turnover19.61x23.19x30.12x43.57x36.42x37.05x31.91x22.05x15.68x4.52x----------
Goodwill00000000000000000000
Intangible Assets7.09M7.19M7.28M7.38M7.48M4.55M4.64M4.73M4.82M4.91M5M000000000
Long-Term Investments00000000000000000000
Other Non-Current Assets13.38M21.11M23.5M00000000000000000
Total Assets1.43B1.24B1.23B1.26B1.36B1.02B996.63M1.04B1.07B1.1B1.08B640.55M237.96M302.46M332.45M362.57M158.64M216.39M222.66M273.33M
Asset Turnover0.32x0.29x0.25x0.24x0.24x0.21x0.13x0.10x0.06x0.01x----------
Asset Growth %5.28%22.58%23.15%20.85%26.95%-7.67%-7.91%62.71%351.02%263.61%225.55%76.67%50%39.77%49.31%32.65%-47.93%-34.02%-28.11%-4.76%
Total Current Liabilities454.24M374.2M338.26M310.29M391.41M196.5M167.24M169.28M177.85M125.16M114.34M118.55M99.67M99.71M98.35M115.89M98.92M84.01M76.64M76.84M
Accounts Payable61.37M34.51M60.8M48.88M44.94M37.98M42.06M43.6M45.97M8.99M21.53M28.04M16.54M17.53M12.13M23.83M18.56M11.29M22.78M21.38M
Days Payables Outstanding116.63108.4183.84176.52210.47401.7854.081.2K1.17K2.18K----------
Short-Term Debt01.03M1.7M1.02M0000000000000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities00241.43M260.39M027.69M18.27M34.96M29.68M21.34M16.95M17.03M9.96M5.45M11.21M14.86M5.05M3.58M2.71M6.77M
Current Ratio3.05x3.20x3.50x4.01x3.44x5.11x5.91x6.10x5.98x8.72x9.39x5.38x2.36x3.02x3.37x3.12x1.59x2.55x2.89x3.54x
Quick Ratio2.78x2.94x3.16x3.77x3.26x4.78x5.58x5.90x5.93x8.67x9.39x5.38x2.36x3.02x3.37x3.12x1.59x2.55x2.89x3.54x
Cash Conversion Cycle198.16179.52175.97130.21157.49224.3674.22-587.14-809.7-1.57K----------
Total Non-Current Liabilities353.2M346.72M345.61M346.61M345.32M122.9M118.75M118.59M118.26M117.51M117.18M116.67M116.05M99.25M83.97M49.29M49.05M48.85M283K387K
Long-Term Debt341.27M340.79M340.33M346.61M339.75M118.38M118M117.57M117.09M116.61M116.14M115.48M114.73M99.25M83.97M49.29M48.98M48.67M00
Capital Lease Obligations11.93M5.92M5.28M6.73M5.57M4.52M750K1.02M1.18M900K1.04M1.19M1.32M00071K178K283K387K
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities000-6.73M0000000000000000
Total Liabilities807.45M720.92M683.87M656.9M736.73M319.4M285.99M287.86M296.11M242.67M231.52M235.21M215.72M198.96M182.31M165.18M147.97M132.86M76.92M77.22M
Total Debt354.22M347.75M347.31M354.36M346.4M123.95M119.77M119.57M119.14M118.06M117.72M117.19M116.56M99.66M84.62M49.89M49.81M49.73M696K797K
Net Debt-160.43M55.02M115.12M155.67M50.71M-62.24M-63.88M19.55M-113.54M-376.53M-504.8M17.28M54.51M22.46M-28.69M-281.66M-9.53M-3.54M-41.59M-35.47M
Debt / Equity0.56x0.66x0.64x0.59x0.55x0.18x0.17x0.16x0.15x0.14x0.14x0.29x5.24x0.96x0.56x0.25x4.67x0.60x0.00x0.00x
Debt / EBITDA6.28x-------------------
Net Debt / EBITDA-2.85x-------------------
Interest Coverage7.87x-6.30x-11.07x-6.06x-14.33x-11.95x-21.21x-15.98x-28.07x-40.57x-37.44x-27.25x-27.18x-28.58x-31.92x-50.07x-53.06x-89.68x--
Total Equity626.94M523.72M543.45M602.69M625.73M695.98M710.64M754.38M777.15M857.12M850.76M405.33M22.25M103.51M150.14M197.39M10.67M83.53M145.74M196.11M
Equity Growth %0.19%-24.75%-23.53%-20.11%-19.48%-18.8%-16.47%86.11%3392.99%728.09%466.66%105.35%108.52%23.91%3.01%0.65%-95.46%-69.14%-44.06%-18.28%
Book Value per Share20.6817.9718.7226.8627.8331.3432.1734.4035.7440.0542.5320.511.205.658.2511.450.624.888.5211.49
Total Shareholders' Equity626.94M523.72M543.45M602.69M625.73M695.98M710.64M754.38M777.15M857.12M850.76M405.33M22.25M103.51M150.14M197.39M10.67M83.53M145.74M196.11M
Common Stock2K2K2K2K2K2K2K2K2K2K2K2K2K2K2K2K2K2K2K2K
Retained Earnings-2.19B-2.24B-2.18B-2.09B-2.03B-1.92B-1.88B-1.8B-1.74B-1.64B-1.48B-1.34B-1.22B-1.13B-1.04B-962.66M-876.75M-795.56M-724.83M-667.31M
Treasury Stock00000000000000000000
Accumulated OCI-1.73M808K1.08M873K1.07M1.11M389K468K1.27M-368K-172K468K-42K-89K-86K-32K-237K-447K-402K-80K
Minority Interest00000000000000000000